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Open AccessSHORT REPORTShort ReportCerebrospinal fluid cortisol levels are higher in 
patients with delirium versus controls
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Ruth Andrew2, Jonathan R Seckl2,5 and Alasdair MJ MacLullich*1,2,5
Abstract
Background: High plasma cortisol levels can cause acute cognitive and neuropsychiatric dysfunction, and have been 
linked with delirium. CSF cortisol levels more closely reflect brain exposure to cortisol, but there are no studies of CSF 
cortisol levels in delirium. In this pilot study we acquired CSF specimens at the onset of spinal anaesthesia in patients 
undergoing hip fracture surgery, and compared CSF and plasma cortisol levels in delirium cases versus controls.
Findings: Delirium assessments were performed the evening before or on the morning of operation with a standard 
battery comprising cognitive tests, mental status assessments and the Confusion Assessment Method. CSF and plasma 
samples were obtained at the onset of the operation and cortisol levels measured. Twenty patients (15 female, 5 male) 
aged 62 - 93 years were studied. Seven patients were diagnosed with delirium. The mean ages of cases (81.4 (SD 7.2)) 
and controls (80.5 (SD 8.7)) were not significantly different (p = 0.88). The median (interquartile range) CSF cortisol 
levels were significantly higher in cases (63.9 (40.4-102.1) nmol/L) than controls (31.4 (21.7-43.3) nmol/L; Mann-Whitney 
U, p = 0.029). The median (interquartile range) of plasma cortisol was also significantly higher in cases (968.8 (886.2-
1394.4) nmol/L, than controls (809.4 (544.0-986.4) nmol/L; Mann Whitney U, p = 0.036).
Conclusions: These findings support an association between higher CSF cortisol levels and delirium. This extends 
previous findings linking higher plasma cortisol and delirium, and suggests that more definitive studies of the 
relationship between cortisol levels and delirium are now required.
Background
Delirium is a severe neuropsychiatric syndrome with core
features of acute onset and fluctuating course of inatten-
tion. It mainly affects older people, particularly those
with chronic cognitive impairment, and is commonly
precipitated by acute illness, surgery, trauma or by the
effects of drugs [1]. Delirium occurs in approximately
15% of older medical inpatients and in at least one third
of patients after hip fracture [2]. However, the mecha-
nisms of delirium are under-researched and poorly
understood [3].
Several lines of evidence support the hypothesis that
high levels of cortisol may play a role in the pathophysiol-
ogy of delirium [3,4]. Animals given high doses of gluco-
corticoids show cognitive deficits [5]. In experimental
studies and clinical practice, high doses of cortisol or
other glucocorticoids can cause inattention and other
cognitive deficits [5-8]. Most patients with Cushing's dis-
ease, in which there are sustained high levels of cortisol,
show neuropsychological impairments [9]. Ageing, a
major risk factor for delirium, is associated with dysregu-
lation of the hypothalamic-pituitary-adrenal (HPA) axis.
This dysregulation results in higher glucocorticoid levels
under basal and stressed conditions, and slower return of
cortisol to baseline levels following stress [5,10,11].
Importantly, HPA axis dysregulation is pronounced in
patients with dementia [12], who are at greatly increased
risk of delirium [5]. Further, there is direct evidence that
high plasma cortisol or HPA axis dysregulation occur in
patients with delirium [3,4]. In patients aged 70-90 years
undergoing abdominal surgery, those who developed
delirium had substantially (>30%) higher plasma cortisol
levels immediately, 24 and 48 hours after surgery [13].
O'Keeffe and Devlin [14] examined the relationship
between delirium and the dexamethasone suppression
test in 16 elderly patients with pneumonia. In this test,
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dexamethasone indicates dysregulation of the HPA axis.
Seven of the nine patients with delirium and only one of
the seven non-delirious patients were non-suppressors.
There are no published studies which have examined
links between cerebrospinal fluid (CSF) cortisol levels
and delirium. Determining CSF cortisol levels is poten-
tially important because they provide a more direct and
less variable measure of brain cortisol exposure than
plasma levels, and because CSF cortisol levels are only
variably related to plasma levels [15]. CNS cortisol levels
are modified by multiple factors including the degree of
blood brain permeability [16], the activity of the multi-
drug-resistance gene type-1 P-glycoprotein [17], and ste-
roid metabolising enzymes within the brain, such as 11β-
hydroxysteroid dehydrogenase type 1 [18].
More generally, there are very few studies which have
examined CSF in delirium [19-21], despite the obvious
value of such studies. This may be partly because that
obtaining CSF samples in such patients presents consid-
erable ethical and practical challenges. One method
which avoids many of these challenges is to obtain CSF
samples in patients with hip fracture, who have a high
prevalence of delirium, at the time of induction of spinal
anaesthesia for fracture repair. CSF collection at the time
of spinal anaesthesia has been used in one study on hip
fracture patients [22], which found higher CSF IL-8 levels
in hip fracture patients versus elective arthroplasty con-
trols, but has not yet been used in the study of delirium.
In the present study we tested the hypothesis that delir-
ium is associated with higher CSF and plasma cortisol
levels in older patients with acute hip fracture.
Methods
Participants
We studied patients with acute hip fracture over 60 years
old who were awaiting surgery under spinal anaesthesia.
Patients gave written, informed consent. Exclusion crite-
ria were residence in an institution, a documented history
of dementia or depressive illness, and corticosteroid ther-
apy within the last 10 weeks. The study was approved by
the Scotland A Research Ethics Committee.
Delirium Assessment
Delirium assessments were performed pre-operatively,
no more than 16 hours before the operation, and before
any pre-operative sedative medication. Each assessment
comprised a standard battery of scales (Mini-Mental
State Examination, digit span, the Delirium Symptom
Interview, the Memorial Delirium Assessment Scale and
the Confusion Assessment Method) validated for the
diagnosis of delirium [23]. In this battery these combined
assessments are used to complete the standard and
widely-used Confusion Assessment Method (CAM), an
established instrument for the detection of delirium [24].
The CAM comprises a four-point algorithm for delirium
diagnosis. For a positive diagnosis patients have to show
(a) an acute onset or fluctuating course, and (b) inatten-
tion, and they must also demonstrate (c) disorganised
thinking and/or (d) altered arousal. The comprehensive,
validated battery we used allows each of these features to
be defined, through a combination of patient assessments
(interview, clinical observation, and cognitive testing),
and information from staff, carers, and casenotes.
Sample Collection and Assays
Samples of CSF (2 ml) and clotted blood (10 ml) were
taken before administration of the spinal anaesthestic
agent. Samples were spun at 1000 g for 10 minutes at 4°C.
To check for blood contamination in the CSF, the pellet
was resuspended in 100 ul phosphate buffer saline fol-
lowed by a cytospin. All samples were stored at -80°C
before analysis. Plasma cortisol assays were performed
with a Cortisol-125I RIA (ImmunChem™, MP Biomedi-
cals), with a detection limit of 22.4 nmol/l. CSF cortisol
levels were determined with a cortisol ELISA kit (Sali-
metrics, USA). The detection range for this kit is 0.08 -
82.8 nmol/L.
Statistical analysis
Group differences in cortisol levels were analysed with
the Mann-Whitney U test (two-tailed). Non-parametric
correlation (Spearman's rho) was used to examine the
relationship between CSF and plasma cortisol levels.
Results
Twenty-seven patients were recruited. Two did not
undergo spinal anaesthesia after recruitment, and an
additional patient had their operation postponed. Four
further patients were excluded because of blood contami-
nation of the CSF specimens. The age range of the 20
included subjects in the study was 62-93 years (mean
80.6, SD 8.0). As expected in this group of older hospital
inpatients, many had comorbid disease (Table 1). Opera-
tions started between the hours of 0800 and 1500. The
mean duration between sample acquisition and centrifu-
gation was 1.6 hours (SD 1.1).
Seven patients had delirium according to the Confusion
Assessment Method. The mean ages of cases (81.4 (SD
7.2)) and controls (80.5 (SD 8.7)) were not significantly
different (p = 0.88). Median (interquartile range) CSF
cortisol levels were significantly higher in subjects with
delirium (63.9 (40.4-102.1) nmol/L) than those without
(31.4 (21.7-43.3) nmol/L; Mann-Whitney U, p = 0.029).
(Figure 1). The median (interquartile range) of plasma
cortisol levels was also significantly higher in cases (968.8
(886.2-1394.4) nmol/L) than in controls (809.4 (544.0-
986.4) nmol/L; Mann Whitney U, p = 0.036).
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Table 1: Subject characteristics, and cerebrospinal fluid and plasma cortisol levels
ID no. Age Sex Major 
comorbidities
CSF cortisol
(nmol/L)
Plasma cortisol
(nmol/L)
CASES 1 76 F - 54.9 886.2
2 83 F HT, COPD 63.9 968.8
3 82 F IHD, HT 18.8 669.4
4 85 F IHD, HT 245.0 3053.7
5 93 F IHD, type 2 DM 67.1 1394.4
6 70 M IHD, type 2 DM 40.4 910.6
7 81 F HT, COPD 102.1 1104.2
CONTROLS 8 81 F IHD, HT 29.2 698.3
9 79 M IHD, COPD 46.4 857.4
10 93 F IHD 40.2 838.3
11 90 F - 37.8 897.1
13 87 F - 79.9 1097.0
14 79 M - 31.1 746.0
15 62 F rheumatoid 
arthritis
21.0 1075.6
16 77 F HT 33.3 463.4
17 88 M - 19.5 481.0
18 88 F IHD 46.5 809.4
19 71 F - 22.5 497.7
20 73 F HT 16.1 1100.3
22 79 M IHD 27.0 590.3
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(p = 0.006). The ratios of CSF to plasma cortisol were not
statistically different between the groups (Mann Whitney
U, p = 0.122).
Discussion
The novel finding in this study was that CSF cortisol lev-
els were significantly higher in hip fracture patients with
delirium versus controls. Plasma cortisol levels were also
significantly higher in cases versus controls. The direc-
tion of causation cannot be determined in an observa-
tional study, but these findings are consistent with the
hypothesis that high brain cortisol levels are associated
with delirium.
Higher levels of cortisol occurring after hip fracture are
an essential part of the systemic response to injury. Con-
sistent with this, the CSF cortisol levels in the present
study were generally considerably higher than those in
healthy younger control subjects (mean 12.3, SEM
1.26)[15], in healthy older people (mean 8.3, SEM
0.55)[25], or in patients with Alzheimer's disease (mean =
21.90, SD = 8.1)[26]; the levels were around half of those
in patients with septic meningitis (median 133 nmol/L
(interquartile range 59-278)[27]. Two patients with delir-
ium had extremely high CSF cortisol levels (cases 4 and
7), of 102.1 and 245.0 nmol/L. The causes of this degree
of elevation is uncertain, but very high plasma cortisol
levels of several thousand nmol/L are commonly
observed in critically ill patients [28]. These extreme lev-
els may reflect the severity of illness in combination with
loss of feedback regulation.
There is good evidence that the degree of elevation of
cortisol, even within the 'stress' range, is important in
causing cognitive dysfunction. For example, in healthy
young males, high doses of administered cortisol over
four days (reaching plasma levels of 700-800 nmol/L)
caused verbal memory impairment [8] and in another
study continuous infusion of high-dose cortisol caused
impairments in working memory [6]. Thus, although ele-
vated levels of cortisol are a critical component of the
physiological response to injury, pathologically high cor-
tisol levels might be more likely to impair cognitive func-
tioning, and even precipitate delirium in vulnerable
patients [13]. Another important factor may be individual
differences in vulnerability to cortisol-induced cognitive
dysfunction [3]. Indeed, in this study levels of cortisol in
cases and controls showed some overlap.
Some limitations of the study should be noted. The
sample size was relatively small. Dementia is a risk factor
for delirium and is also associated with higher CSF corti-
sol levels[26], and so is a potential confounder, though in
the present study patients with known dementia were
excluded. However, future studies would benefit from
more detailed screening of patients, and retrospective
informant history, for example with the Informant Ques-
tionnaire on Cognitive Decline in the Elderly
(IQCODE)[29]. CSF sampling occurred at different times
of the day; however this may not be important because of
the loss of diurnal rhythm of cortisol in the early phase
after a fracture [30]. Another limitation is that some
delirium assessments took place the evening before sur-
gery, several hours before the cortisol measurements.
Future studies should aim to conduct these assessments
and measurements as close together as possible. Addi-
tionally, possible interactions between drugs known to
precipitate delirium, and cortisol levels, should be
explored.
These results suggest that patients with delirium have
higher levels of cortisol in the CSF and plasma. Should a
causal role for cortisol be established, this would suggest
a potential role for antiglucocorticoid therapies in delir-
ium.
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